This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Transform Pharmaceuticals, Inc., Janssen Biotech, Inc., Mcneil-Ppc, Inc.. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Arlington, MA (US) (2004 - 2007)
- Acton, MA (US) (2005 - 2013)
Company Filing History:
6 out of 28 
1 out of 435 
1 out of 798 Years Active: 2004-2013
Title: Innovations by Inventor Hongming Chen
Introduction
Hongming Chen is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on improving drug solubility and bioavailability, which are critical factors in pharmaceutical development.
Latest Patents
One of his latest patents is titled "Pharmaceutical compositions with improved dissolution." This invention relates to methods of screening mixtures containing a pharmaceutical compound and an excipient to identify properties that retard solid-state nucleation. It further aims to increase the solubility, dissolution, and bioavailability of drugs with low solubility in gastric fluid conditions by combining the drug with a precipitation retardant and an optional enhancer. Another significant patent is "Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses." This invention provides aqueous pharmaceutical compositions containing the lipophilic therapeutic agent propofol. The preferred compositions include propofol in the presence of at least one block copolymer and a polyethylene glycol (PEG). These compositions are designed to be sterile and suitable for parenteral administration, ensuring stability over a wide range of environmental conditions.
Career Highlights
Throughout his career, Hongming Chen has worked with prominent companies in the pharmaceutical industry, including Transform Pharmaceuticals, Inc. and Janssen Biotech, Inc. His expertise in drug formulation and development has made him a valuable asset in these organizations.
Collaborations
Hongming has collaborated with notable professionals in his field, including Zhong Zhang and Orn Almarsson. These collaborations have likely contributed to the innovative advancements in his patents.
Conclusion
Hongming Chen's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug efficacy and safety. His patents reflect a deep understanding of pharmaceutical science and a dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile